Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1478-6362

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol ; volume:23 ; number:1 ; day:29 ; month:10 ; year:2021 ; pages:1-11 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (29.10.2021), 1-11, 12.2021

Creator: Maksymowych, Walter P.
Kumke, Thomas
Auteri, Simone E.
Hoepken, Bengt
Bauer, Lars
Rudwaleit, Martin

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13075-021-02650-4

URN: urn:nbn:de:101:1-2022010821360998505282

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:32 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Maksymowych, Walter P.
Kumke, Thomas
Auteri, Simone E.
Hoepken, Bengt
Bauer, Lars
Rudwaleit, Martin
SpringerLink (Online service)

Other Objects (12)

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy

Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements

Work Disability in Axial Spondyloarthritis

Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years

The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland

MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

P190: Cardiovascular Disease in Axial Spondyloarthritis

Targeting inflammatory pathways in axial spondyloarthritis

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy

Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements

Work Disability in Axial Spondyloarthritis

Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years

The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland

MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

P190: Cardiovascular Disease in Axial Spondyloarthritis

Targeting inflammatory pathways in axial spondyloarthritis

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy

Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements

Work Disability in Axial Spondyloarthritis

Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years

The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland

MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

P190: Cardiovascular Disease in Axial Spondyloarthritis

Targeting inflammatory pathways in axial spondyloarthritis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy

Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements

Work Disability in Axial Spondyloarthritis

Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years

The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland

MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

P190: Cardiovascular Disease in Axial Spondyloarthritis

Targeting inflammatory pathways in axial spondyloarthritis

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy

Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements

Work Disability in Axial Spondyloarthritis

Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years

The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland

MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

P190: Cardiovascular Disease in Axial Spondyloarthritis

Targeting inflammatory pathways in axial spondyloarthritis

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy

Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements

Work Disability in Axial Spondyloarthritis

Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years

The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis

Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland

MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial

P190: Cardiovascular Disease in Axial Spondyloarthritis

Targeting inflammatory pathways in axial spondyloarthritis

Related objects

Reset password